Proven solutions for successful market launches of new medical products and services, successful integration of innovations in healthcare.
"To obtain a regulatory approval and reach the market, a biotechnology development must successfully undergo preclinical and clinical trials (PCTs and CTs). The procedure for conducting these tests is strictly regulated, and the regulator evaluates the testing results thoroughly. Because of this, biotech companies normally conduct PCTs and CTs at accredited contract research organizations (CROs).
Artgen’s experience and expertise help create proper trial protocols, optimize their cost and timing, and increase the probability of successful completion of PCTs and CTs.
Obtaining a marketing authorization (MA), conducting PCTs and CTs require a licensed high-tech site that meets strict GMP (good manufacturing practice) rules.
Organizing such a production facility is a long and costly process that requires a variety of highly qualified experts and competencies. It is extremely difficult for biotech startups to organize a production facility of this level on their own.
Artgen provides the necessary competencies for the development of industrial regulations, production of primary batches, creation of a set of production documents, and technology transfer.
Market access is the work that must be done for a registered drug to reach the market. It means that physicians will be able to prescribe the drug to patients in accordance with clinical guidelines, medical institutions will be able to purchase it in accordance with the lists (EDL) and medical standards (DRG, GVD), and insurance companies will be able to reimburse the costs of treatment using the drug.
The biotechnology market is an area with high entry barriers. Therefore, for a product to be implemented successfully, PR (public relations), GR (government relations), and IR (investor relations) must begin long before registration to gain support for the product even before it enters the market.
Artgen’s experience and expertise allow us to build and maintain long-term and effective communications with physicians, patients, investors, representatives of regulators and development institutes, which contributes to the successful implementation and distribution of the ecosystem developments.
ЗCosts of biotech companies increase as their development gets closer to market, prompting the need for new fundraising rounds. Whatever the investment source, a venture capital fund, an IPO, or private placement, investors expect their investments to grow and regular reports on the company’s financial results and performance. This is why effective capital management competencies are just as important as the fundraising experience. The key function of investment management is to ensure the efficient use of investments and protect the capital interests.
Artgen’s ecosystem acts as an “investment bank”, providing a full range of specialized services for the group companies:
Medical marketing means actions aimed at promoting, implementing in medical practice, and increasing sales of medical services, products, or technologies.
It uses a number of tools: